Skip to main content
. 2025 Aug 1;12:1598453. doi: 10.3389/fcvm.2025.1598453

Figure 1.

Flowchart showing patient selection for derivation and validation cohorts in a coronary artery disease study. In the derivation cohort, 126 patients from January 2022 to December 2023 were screened; 11 were excluded due to factors like inadequate acoustic windows or valvular disease, leaving 115 patients divided into two groups: CFVR less than 2.5 (n=48) and CFVR 2.5 or greater (n=67). In the validation cohort, 62 patients from January to July 2024 were equally divided into the same CFVR categories, with 31 patients in each group.

Patient flowchart in the study.